AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

JUDGES SCIENTIFIC PLC

Director's Dealing May 9, 2016

7734_dirs_2016-05-09_a62240f6-db8c-4fee-a409-b837b16acdac.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6950X

Judges Scientific PLC

09 May 2016

Press Release 9 May 2016

Judges Scientific plc

("Judges Scientific", "Judges", the "Company" or the "Group")

Director/PDMR Shareholding

Judges Scientific, a group involved in the buy and build of scientific instrument businesses, has today been advised that purchases of ordinary shares of 5p each in the Company ("Ordinary Shares") were made on 5 May 2016 by the Trustees of the Share Incentive Plan on behalf of three Directors of the Company, as follows:

A total of 16 Ordinary Shares were purchased on behalf of David Cicurel, the Chief Executive Officer of the Company.  His resulting interest in the Company is 916,725 Ordinary shares representing 15.02 per cent of the issued Ordinary Share capital.  In addition, he holds options over 9,275 Ordinary Shares under the Company's Share Option Plans.

A total of 16 Ordinary shares were purchased on behalf of Brad Ormsby, the Group Finance Director of the Company.  His resulting interest in the Company is 150 Ordinary Shares representing nil per cent of the issued Ordinary Share capital.  In addition, he holds options over 60,000 Ordinary Shares under the Company's Share Option Plans.

A total of 133 Ordinary shares were purchased on behalf of David Barnbrook, the Chief Operating Officer of the Company.  His resulting interest in the Company is 19,836 Ordinary Shares representing 0.33 per cent of the issued Ordinary Share capital.  In addition, he holds options over 28,325 Ordinary Shares under the Company's Share Option Plans.

The purchases by the Trustees were made at a price of 1,802.4p per Ordinary Share.  Purchases of a further 852 Ordinary Shares were made on the same date and at the same price on behalf of 81 other members of staff under the Company's Share Incentive Plan.

-Ends-

For further information please contact:

Judges Scientific
David Cicurel, CEO

Brad Ormsby, Group FD
Tel: +44 (0) 203 829 6970
Shore Capital (Nominated Adviser & Broker)
Stephane Auton

Edward Mansfield
Tel: +44 (0) 20 7408 4090
Media enquiries:

Abchurch (Financial Public Relations)
Julian Bosdet

Canace Wong

Nessyah Hart
Tel: +44 (0) 20 7398 7714

www.abchurch-group.com

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses.  The Group currently consists of 14 businesses acquired since it was first admitted to AIM in 2003.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities.  The UK is a recognised centre of excellence for scientific instruments. The Group companies hold five Queen's Awards for innovation and export.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

The Group's companies predominantly operate in niche end markets, with long term growth fundamentals and resilient margins.

For further information, please visit www.judges.uk.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBSGDULUGBGLC

//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'zw_3hFWyyYCSQxU2T0W9Uo74p8rcSqKCNsjfA-l13Ekm5IOTdzU6GFTGMSOAI26LQoCx4f4xY8O6xX_lGr1RQ5x2FNn0wl-z2ROlczRYquI1:37XevswK6oCYh6WyhB5AsOgPATCSqKKKbtQM3PmbOvn8jm0DLgmY7aXox--fvCN3uzRMyn0sYNji49OrzKBDv8iYvES9dfXRi6EKPObAceI1'}});//]]>

Talk to a Data Expert

Have a question? We'll get back to you promptly.